Acinetobacter spp
% high level resistance to ceftazidime by hospital
All clinical specimens
(January-June 2002)

WARDS
Hospital
Isolates
tested
% NS
% R
%I
GR051
5
20,00%
20,00%
0,00%
GR001
16
37,50%
37,50%
0,00%
GR027
10
40,00%
30,00%
10,00%
GR015
25
48,00%
36,00%
12,00%
GR008
2
 
 
 
GR049
2
 
 
 
GR040
98
61,22%
59,18%
2,04%
GR014
62
61,29%
56,45%
4,84%
GR042
16
62,50%
50,00%
12,50%
GR026
16
62,50%
62,50%
0,00%
GR022
19
68,42%
68,42%
0,00%
GR039
96
69,79%
62,50%
7,29%
GR018
17
70,59%
64,71%
5,88%
GR012
21
76,19%
71,43%
4,76%
GR047
38
76,32%
68,42%
7,89%
GR032
11
81,82%
54,55%
27,27%
GR005
23
82,61%
82,61%
0,00%
GR050
56
85,71%
80,36%
5,36%
GR004
7
85,71%
85,71%
0,00%
GR038
16
87,50%
81,25%
6,25%
GR048
8
87,50%
62,50%
25,00%
GR013
11
90,91%
81,82%
9,09%
GR030
64
93,75%
75,00%
18,75%
GR007
27
100,00%
96,30%
3,70%
GR033
21
100,00%
100,00%
0,00%
GR043
6
100,00%
83,33%
16,67%
Grand Total
693
73,16%
66,38%
6,78%
 
 
 
 
 
Hospital Mean
 
72,91%
65,44%
7,47%
    
ICU
Isolates
tested
% NS
%R
%I
 
 
 
 
21
57,14%
52,38%
4,76%
2
 
 
 
 
 
 
 
 
 
 
 
3
 
 
 
119
56,30%
52,10%
4,20%
129
93,80%
93,02%
0,78%
 
 
 
 
 
 
 
 
17
100,00%
100,00%
0,00%
137
92,70%
85,40%
7,30%
 
 
 
 
28
85,71%
82,14%
3,57%
19
94,74%
89,47%
5,26%
 
 
 
 
31
96,77%
96,77%
0,00%
 
 
 
 
1
 
 
 
 
 
 
 
10
90,00%
80,00%
10,00%
4
 
 
 
65
 
 
 
24
100,00%
87,50%
12,50%
46
100,00%
100,00%
0,00%
7
100,00%
100,00%
0,00%
663%
86,88%
82,96%
3,92%
 
 
 
 
 
88,93%
84,90%
4,03%